Cargando…

Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19

BACKGROUND: Long-lasting symptoms following SARS-CoV2-infection have been described in several studies. However, there is only limited knowledge about the ongoing pathophysiology and the association with pathological findings in medical examinations. METHODS: In this post hoc analysis of a prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Antje, Gysan, Maximilian, Bernitzky, Dominik, Bal, Christina, Prosch, Helmut, Zehetmayer, Sonja, Milos, Ruxandra-Iulia, Vonbank, Karin, Pohl, Wolfgang, Idzko, Marco, Gompelmann, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109200/
https://www.ncbi.nlm.nih.gov/pubmed/35578190
http://dx.doi.org/10.1186/s12890-022-01987-z
_version_ 1784708856036720640
author Lehmann, Antje
Gysan, Maximilian
Bernitzky, Dominik
Bal, Christina
Prosch, Helmut
Zehetmayer, Sonja
Milos, Ruxandra-Iulia
Vonbank, Karin
Pohl, Wolfgang
Idzko, Marco
Gompelmann, Daniela
author_facet Lehmann, Antje
Gysan, Maximilian
Bernitzky, Dominik
Bal, Christina
Prosch, Helmut
Zehetmayer, Sonja
Milos, Ruxandra-Iulia
Vonbank, Karin
Pohl, Wolfgang
Idzko, Marco
Gompelmann, Daniela
author_sort Lehmann, Antje
collection PubMed
description BACKGROUND: Long-lasting symptoms following SARS-CoV2-infection have been described in several studies. However, there is only limited knowledge about the ongoing pathophysiology and the association with pathological findings in medical examinations. METHODS: In this post hoc analysis of a prospective trial, 135 patients following COVID-19 were enrolled and grouped with respect to the presence or absence of respiratory ongoing symptoms following COVID-19. Pulmonary function test (PFT), diffusion capacity measurement (TLCO SB and TLCO/VA), blood gas analysis (BGA), laboratory tests and high-resolution computed tomography (HRCT) of patients with persistent respiratory symptoms were compared to those of asymptomatic patients. RESULTS: In this analysis, 71% (96/135) of all patients (mean age 49 years; range 20–91 years) reported long-lasting symptoms after a median (IQR) of 85 days (60–116) following COVID-19 whereby 57.8% (78/135) complained about persistent pulmonary symptoms. Pathological findings in blood test, PFT, TLCO, BGA and/or HRCT were found in 71.8% and 64.1% of patients with and without long-lasting respiratory symptoms respectively. Patients with persistent respiratory symptoms were significantly younger and presented a significant lower FVC (%), TLC (L), and TLCO SB compared to asymptomatic patients (p < 0.05). The multiple logistic regression results in a significant effect of age (p = 0.004) and TLCO SB (p = 0.042). CONCLUSION: Following COVID-19, a large proportion of patients experience ongoing symptoms, whereby the respiratory symptoms are the predominant complaints. Compared to asymptomatic patients, patients with ongoing symptoms were younger and presented a significant lower FVC, TLC and TLCO SB. The multiple logistic regression demonstrated only a significant association between the TLCO SB as the only PFT parameter and the perceived symptoms.
format Online
Article
Text
id pubmed-9109200
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91092002022-05-16 Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19 Lehmann, Antje Gysan, Maximilian Bernitzky, Dominik Bal, Christina Prosch, Helmut Zehetmayer, Sonja Milos, Ruxandra-Iulia Vonbank, Karin Pohl, Wolfgang Idzko, Marco Gompelmann, Daniela BMC Pulm Med Research BACKGROUND: Long-lasting symptoms following SARS-CoV2-infection have been described in several studies. However, there is only limited knowledge about the ongoing pathophysiology and the association with pathological findings in medical examinations. METHODS: In this post hoc analysis of a prospective trial, 135 patients following COVID-19 were enrolled and grouped with respect to the presence or absence of respiratory ongoing symptoms following COVID-19. Pulmonary function test (PFT), diffusion capacity measurement (TLCO SB and TLCO/VA), blood gas analysis (BGA), laboratory tests and high-resolution computed tomography (HRCT) of patients with persistent respiratory symptoms were compared to those of asymptomatic patients. RESULTS: In this analysis, 71% (96/135) of all patients (mean age 49 years; range 20–91 years) reported long-lasting symptoms after a median (IQR) of 85 days (60–116) following COVID-19 whereby 57.8% (78/135) complained about persistent pulmonary symptoms. Pathological findings in blood test, PFT, TLCO, BGA and/or HRCT were found in 71.8% and 64.1% of patients with and without long-lasting respiratory symptoms respectively. Patients with persistent respiratory symptoms were significantly younger and presented a significant lower FVC (%), TLC (L), and TLCO SB compared to asymptomatic patients (p < 0.05). The multiple logistic regression results in a significant effect of age (p = 0.004) and TLCO SB (p = 0.042). CONCLUSION: Following COVID-19, a large proportion of patients experience ongoing symptoms, whereby the respiratory symptoms are the predominant complaints. Compared to asymptomatic patients, patients with ongoing symptoms were younger and presented a significant lower FVC, TLC and TLCO SB. The multiple logistic regression demonstrated only a significant association between the TLCO SB as the only PFT parameter and the perceived symptoms. BioMed Central 2022-05-16 /pmc/articles/PMC9109200/ /pubmed/35578190 http://dx.doi.org/10.1186/s12890-022-01987-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lehmann, Antje
Gysan, Maximilian
Bernitzky, Dominik
Bal, Christina
Prosch, Helmut
Zehetmayer, Sonja
Milos, Ruxandra-Iulia
Vonbank, Karin
Pohl, Wolfgang
Idzko, Marco
Gompelmann, Daniela
Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
title Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
title_full Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
title_fullStr Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
title_full_unstemmed Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
title_short Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
title_sort comparison of pulmonary function test, diffusion capacity, blood gas analysis and ct scan in patients with and without persistent respiratory symptoms following covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109200/
https://www.ncbi.nlm.nih.gov/pubmed/35578190
http://dx.doi.org/10.1186/s12890-022-01987-z
work_keys_str_mv AT lehmannantje comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT gysanmaximilian comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT bernitzkydominik comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT balchristina comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT proschhelmut comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT zehetmayersonja comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT milosruxandraiulia comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT vonbankkarin comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT pohlwolfgang comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT idzkomarco comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19
AT gompelmanndaniela comparisonofpulmonaryfunctiontestdiffusioncapacitybloodgasanalysisandctscaninpatientswithandwithoutpersistentrespiratorysymptomsfollowingcovid19